Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
November 14, 2014
RANBAXY LABORATORIES, LTD et al v. BURWELL et al
Case Number:
1:14-cv-01923
Court:
Nature of Suit:
Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
- Axinn Veltrop
- Crisham & Holman
- Goodwin Procter
- Hagens Berman
- Hyman Phelps
- Kirkland & Ellis
- Lowey Dannenberg
Companies
- Dr. Reddy's Laboratories Ltd.
- Endo International PLC
- Meijer Inc.
- Ranbaxy
- Teva Pharmaceutical Industries Ltd.
- United Food & Commercial Workers International Union
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 11, 2015
FDA Beats Ranbaxy Suit Despite 'Serious' Approval Errors
The U.S. Food and Drug Administration acted within its authority when it stripped Ranbaxy Laboratories Ltd. of tentative approvals for two generics, but the agency also made "serious errors" by granting those approvals in the first place, according to a D.C. federal court ruling unsealed Wednesday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login